logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Court of Appeal reserves judgment in important SEN case

20 October 2011

A father of a child with Down's Syndrome is challenging a local authority's (LA) decision to cease funding his 22 year old daughter's education. He wants her education to continue until she is 25.

This case will hopefully clarify LA obligations around when they can lawfully cease to maintain a statement of SEN. Current guidance recommends LAs maintain statements until the age of 19. Yet the proportion of children and young adults with Down’s Syndrome staying longer in schools continues to increase. If the Court of Appeal decides that a LA should educate a pupil with SEN until they reach 25, it will force LAs to carefully examine the provision for these individuals alongside younger students, both practically (e.g. safeguarding) and financially.

The outcome of this case is awaited by many interested parties. However, the Court of Appeal have rightly reserved judgement to a later date. This case will require careful scrutiny and a sound grasp of the wide-ranging consequences on all those affected by the decision.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up